81
Views
9
CrossRef citations to date
0
Altmetric
Original Research

Pattern of statin use changes following media coverage of its side effects

, &
Pages 1151-1157 | Published online: 10 Jul 2017

References

  • Scandinavian Simvastatin Survival Study GroupRandomised trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study (4S)Lancet19943448934138313897968073
  • OngHTThe statin studies: from targeting hypercholesterolaemia to targeting the high-risk patientQJM200598859961416006501
  • PerkJDe BackerGGohlkeHEuropean Guidelines on cardiovascular disease prevention in clinical practice (version 2012)Eur Heart J201233131635170122555213
  • Wallach KildemoesHVassMHendriksenCAndersenMStatin utilization according to indication and age: a Danish cohort study on changing prescribing and purchasing behaviourHealth Policy20121082–321622722975117
  • GodmanBShrankWAndersenMPolicies to enhance prescribing efficiency in Europe: findings and future implicationsFront Pharmacol2011114121833180
  • KildemoesHWHendriksenCAndersenMDrug utilization according to reason for prescribing: a pharmacoepidemiologic method based on an indication hierarchy2012211010271035
  • GuQPaulose-RamRBurtVLKitBKPrescription cholesterol-lowering medication use in adults aged 40 and over: United States, 2003–2012NCHS Data Brief201417718
  • WalleyTFolino-GalloPStephensPVan GanseETrends in prescribing and utilization of statins and other lipid lowering drugs across Europe 1997–2003Br J Clin Pharmacol200560554355116236045
  • PyöräläKBackerGDGrahamIPoole-wilsonPWoodDPrevention of coronary heart disease in clinical practice. Recommendations of the Task Force of the European Society of Cardiology, European Atherosclerosis Society and European Society of HypertensionEur Heart J19941510121161
  • Wallach-KildemoesHAndersenMDiderichsenFLangeTAdherence to preventive statin therapy according to socioeconomic positionEur J Clin Pharmacol20136981553156323588558
  • NixonMKousgaardMBOrganising medication discontinuation: a qualitative study exploring the views of general practitioners toward discontinuing statinsBMC Health Serv Res20161622627388025
  • Mantel-TeeuwisseAKGoettschWGKlungelOHde BoerAHeringsRMLong term persistence with statin treatment in daily medical practiceHeart20049091065106615310708
  • Helin-SalmivaaraALavikainenPKorhonenMJLong-term persistence with statin therapy: a nationwide register study in FinlandClin Ther200830Pt 22228224019281917
  • ZhangHPlutzkyJSkentzosSDiscontinuation of statins in routine care settings: a cohort studyAnn Intern Med2013158752653423546564
  • Danish Health AuthoritiesFocus Report on Statins–Knowledge about Use and Side Effects of StatinsCopenhagenDanish Health Authorities2012
  • ScheufeleDAFraming as a theory of media effectsJ Commun1999491103122
  • UedaMMoriKMatsubayashiTThe effects of media reports of suicides by well-known figures between 1989 and 2010 in Japan201442623629
  • MartinRMMayMGunnellDDid intense adverse media publicity impact on prescribing of paroxetine and the notification of suspected adverse drug reactions? Analysis of routine databases, 2001–2004Br J Clin Pharmacol200661222422816433877
  • BrounéusFDahlinABeermannBPress coverage and sales of Xenical in Sweden, 1998–2000Eur J Clin Pharmacol200561428528915895270
  • ArcherDFMedical decisions regarding hormone therapy for menopausal women are significantly influenced by the mediaPharmacoepidemiol Drug Saf2007161283117177322
  • NielsenSFNordestgaardBGNegative statin-related news stories decrease statin persistence and increase myocardial infarction and cardiovascular mortality: a nationwide prospective cohort studyEur Heart J2016371190891626643266
  • JacobsonTAToward “pain-free” stain prescribing: clinical algorithm for diagnosis and management of myalgiaMayo Clin Proc200883668770018533086
  • TaylorBAThompsonPDMuscle-related side-effects of statins: from mechanisms to evidence-based solutionsCurr Opin Lipidol201526322122725943841
  • MatthewsAHerrettEGasparriniAImpact of statin related media coverage on use of statins: interrupted time series analysis with UK primary care dataBMJ2016353975316701681
  • SchafferALBuckleyNADobbinsTABanksEPearsonSAThe crux of the matter: did the ABCs’ catalyst program change statin use in Australia?Med J Aust20152021159159526068693
  • CraigPCooperCGunnellDUsing natural experiments to evaluate population health interventions: guidance for producers and users of evidenceMed Res Counc2011129
  • SedjoRLCoxERLowering copayments: impact of simvastatin patent expiration on patient adherenceAm J Manag Care2008141281381819067498
  • ThygesenLCDaasnesCThaulowIBronnum-HansenHIntroduction to Danish (nationwide) registers on health and social issues: structure, access, legislation, and archivingScand J Public Health201139Suppl 7121621898916
  • LyngeESandegaardJLReboljMThe Danish National Patient RegisterScand J Public Health201139Suppl 7303321775347
  • GaistDSørensenHTHallasJThe Danish prescription registriesDan Med Bull19974444454489377907
  • KildemoesHWSorensenHTHallasJThe Danish National Prescription RegistryScand J Public Heal201139Suppl 73841
  • AndradeSEKahlerKHFrechFChanKAMethods for evaluation of medication adherence and persistence using automated databasesPharmacoepidemiol Drug Saf200615856557416514590
  • Wallach-KildemoesHStovringHHolme HansenEHowseKPéturssonHStatin prescribing according to gender, age and indication: what about the benefit-risk balance?J Eval Clin Pract201622223524626446680
  • ShafferALBuckleyNADobbinsTABanksEPearsonSAThe crux of the matter: Did the ABC’s Catalyst program change statin use in Australia?Med J Aust20152021159159526068693